Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Perspective Therapeutics Inc shares valued at $49,384 were purchased by Spoor Johan M. on Mar 28 ’25. At $2.24 per share, Spoor Johan M. acquired 22,026 shares. The insider’s holdings grew to 59,383 shares worth approximately $0.2 million following the completion of this transaction.
Also, Spoor Johan M. purchased 4,650 shares, netting a total of over 10,288 in proceeds. Following the buying of shares at $2.21 each, the insider now holds 4,650 shares.
Before that, Williamson Robert F III had added 38,145 shares to its account. In a trade valued at $81,775, the Director bought Perspective Therapeutics Inc shares for $2.14 each. Upon closing the transaction, the insider’s holdings increased to 38,145 shares, worth approximately $0.38 million.
As published in their initiating research note from H.C. Wainwright on March 13, 2025, Perspective Therapeutics Inc [CATX] has been a Buy and the price target has been revised to $10. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in early March. As of November 25, 2024, BofA Securities has decreased its “Buy” rating to a “Neutral” for CATX. Earlier on October 24, 2024, UBS initiated its rating. Their recommendation was “a Buy” for CATX stock.
Analyzing CATX Stock Performance
On last trading session,, Perspective Therapeutics Inc [AMEX: CATX] plunged -2.27% to $3.45. The stock’s lowest price that day was $3.43, but it reached a high of $3.63 in the same session. During the last five days, there has been a surge of approximately 5.18%. Over the course of the year, Perspective Therapeutics Inc shares have jumped approximately 8.15%. Shares of the company reached a 52-week high of $4.24 on 01/24/25 and a 52-week low of $1.60 on 04/09/25.
Support And Resistance Levels for Perspective Therapeutics Inc (CATX)
According to the 24-hour chart, there is a support level at 3.38, which, if violated, would cause prices to drop to 3.30. In the upper region, resistance lies at 3.58. The next price resistance is at 3.70. RSI (Relative Strength Index) is 62.21 on the 14-day chart, showing neutral technical sentiment.
Is Perspective Therapeutics Inc subject to short interest?
Stocks of Perspective Therapeutics Inc saw a sharp rise in short interest on 2025-05-30 jumping by 11675.0 shares to 5.28 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 5.27 million shares. A jump of 0.22% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.4 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.4.
Which companies own the most shares of Perspective Therapeutics Inc (CATX)?
In terms of Perspective Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 21 in the next 12 months, up nearly 494.9% from the previous closing price of $3.53. Analysts anticipate Perspective Therapeutics Inc stock to reach 24 by 2025, with the lowest price target being 3. In spite of this, 4 analysts ranked Perspective Therapeutics Inc stock as Buy at the end of 2025. On October 01, 2024, Wedbush assigned a price target of “an Outperform” to the stock and initiated coverage with a $25.
